Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study

Affiliations

• ¹ CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China qixiaolong@vip.163.com herr_xiong@126.com.
• ² CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
• ³ CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
• ⁴ Centre for Inflammation Research, University of Edinburgh MRC Centre for Inflammation Research, Edinburgh, UK.
• ⁵ Department of Tuberculosis and Respiratory, Wuhan Jinyintan Hospital, Wuhan, China.
• ⁶ Department of Infectious Disease, Shanghai Fifth People's Hospital of Fudan University, Shanghai, China.
• ⁷ Department of Respiratory Medicine, Shanghai Fifth People's Hospital of Fudan University, Shanghai, China.
• ⁸ Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.
• ⁹ Department of Respiratory Medicine, The People's Hospital of Baoding, Baoding, China.
• ¹⁰ Department of Gastroenterology, Tianjin Haihe Hospital, Tianjin, China.
• ¹¹ Department of Respiratory Medicine, Suizhou Hospital, Hubei University of Medicine, Suizhou, China.
• ¹² Department of Respiratory Medicine, Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China.
• ¹³ Department of Radiology, Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China.
• ¹⁴ Department of Infectious Disease, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China.
• ¹⁵ Department of Infectious Disease, The Central Hospital of Lichuan, Enshi, China.
• ¹⁶ MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
• ¹⁷ CHESS-COVID-19 Group, The Third People's Hospital of Shenzhen, Shenzhen, China.
• ¹⁸ CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, China.
• ¹⁹ CHESS-COVID-19 Group, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
• ²⁰ CHESS-COVID-19 Group, Zhejiang University Lishui Hospital and Lishui Central Hospital, Lishui, China.
• ²¹ Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
• ²² The First Hospital of Lanzhou University, Lanzhou, China.
• ²³ Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
• ²⁴ Department of Infectious Disease, Ankang Central Hospital, Ankang, China.
• ²⁵ Department of Gastroenterology and Hepatology, Tianjin Second People's Hospital, Tianjin, China.
• ²⁶ Department of Radiology, Wuhan Union Hospital, Wuhan, China qixiaolong@vip.163.com herr_xiong@126.com.
• ²⁷ Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
• ²⁸ Division of Gastroenterology and Hepatology, Medical University South Carolina, Charleston, South Carolina, USA.